PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.00%
Negative revenue growth while ANO.AX stands at 0.86%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-0.00%
Negative gross profit growth while ANO.AX is at 277.40%. Joel Greenblatt would examine cost competitiveness or demand decline.
0.00%
EBIT growth below 50% of ANO.AX's 69.76%. Michael Burry would suspect deeper competitive or cost structure issues.
0.00%
Operating income growth under 50% of ANO.AX's 69.76%. Michael Burry would be concerned about deeper cost or sales issues.
0.00%
Net income growth under 50% of ANO.AX's 76.38%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.33%
Share reduction more than 1.5x ANO.AX's 23.52%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-84.63%
Negative 10Y revenue/share CAGR while ANO.AX stands at 8.30%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-69.45%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-57.15%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-115.67%
Negative 5Y OCF/share CAGR while ANO.AX is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-37.87%
Negative 3Y OCF/share CAGR while ANO.AX stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-103.43%
Negative 10Y net income/share CAGR while ANO.AX is at 96.91%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-130.23%
Negative 5Y net income/share CAGR while ANO.AX is 96.96%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
63.17%
3Y net income/share CAGR 50-75% of ANO.AX's 98.48%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.33%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
463.46%
We increase R&D while ANO.AX cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-0.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.